1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-5-oxopyrrolidine-3-carboxylic acid
N-(2,6-Difluorobenzyl)-3-(((4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)methyl)amino)benzamide
2-(Furan-2-yl)-1-methyl-N-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridin-6-amine
Methyl (E)-5-(2-(5-nitrofuran-2-yl)vinyl)furan-2-carboxylate
4-(4-Fluoro-3-((pyridin-2-ylmethyl)carbamoyl)phenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
4-(4-Fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
2-(Cyclopropanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
GSK299115A
GRK5-IN-4
GRK6-IN-1
KR-39038
GRK2 Inhibitor 2
GSK317354A
GRK6-IN-2
CCG-273463
(R,Z)-3-((4-(2-Chloroacetamido)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-N-(1-(4-fluorophenyl)ethyl)-2-oxoindoline-5-carboxamide
N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
GRK5-IN-3
GSK466317A
CCG-271423
